Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
40
CNC Quote, Financials, Valuation and Earnings
Last price:
$62.90
Seasonality move
:
3.8%
Day range:
$62.09 - $63.18
52-week range:
$55.03 - $81.42
Dividend yield:
0%
P/E ratio:
10.87x
P/S ratio:
0.21x
P/B ratio:
1.16x
Volume:
4M
Avg. volume:
5.7M
1-year change:
-19.09%
Market cap:
$31.6B
Revenue:
$154B
EPS (TTM):
$5.76
Analysts' Opinion
-
Consensus RatingCentene has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 6 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $78.92, Centene has an estimated upside of 26.05% from its current price of $62.61.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $52.00 representing 16.95% downside risk from its current price of $62.61.
Fair Value
-
According to the consensus of 15 analysts, Centene has 26.05% upside to fair value with a price target of $78.92 per share.
CNC vs. S&P 500
-
Over the past 5 trading days, Centene has overperformed the S&P 500 by 3.02% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Centene does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Centene has grown year-over-year revenues for 67 quarters straight. In the most recent quarter Centene reported revenues of $42B.
Earnings Growth
-
Centene has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Centene reported earnings per share of $1.36.
Enterprise value:
31.7B
EV / Invested capital:
--
Price / LTM sales:
0.21x
EV / EBIT:
6.83x
EV / Revenue:
0.20x
PEG ratio (5yr expected):
0.37x
EV / Free cash flow:
129.58x
Price / Operating cash flow:
136.08x
Enterprise value / EBITDA:
5.39x
Gross Profit (TTM):
$16.8B
Return On Assets:
3.68%
Net Income Margin (TTM):
1.9%
Return On Equity:
11.5%
Return On Invested Capital:
6.9%
Operating Margin:
1.58%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $141.6B | $150.1B | $161.7B | $38B | $42B | |
| Gross Profit | $16.4B | $17.5B | $16.8B | $4.6B | $4B | |
| Operating Income | $3.9B | $3.9B | $2.9B | $1.2B | $665M | |
| EBITDA | $4.7B | $5.7B | $5.9B | $1.3B | $1.4B | |
| Diluted EPS | $3.43 | $4.45 | $5.76 | $0.87 | $1.36 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $27.3B | $28.1B | $33.3B | $41.4B | $37.4B | |
| Total Assets | $68.4B | $77.7B | $81.2B | $84.4B | $82.4B | |
| Current Liabilities | $21.8B | $25B | $31.3B | $36.9B | $34.1B | |
| Total Liabilities | $42.5B | $51.1B | $55.6B | $59B | $54.9B | |
| Total Equity | $25.9B | $26.7B | $25.6B | $25.4B | $27.4B | |
| Total Debt | $16.8B | $18.8B | $18.3B | $18B | $17.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $8.5B | $6.3B | $958M | $1B | -$978M | |
| Cash From Investing | -$4B | -$21M | -$2.1B | $435M | -$839M | |
| Cash From Financing | -$2.7B | -$3.2B | -$2.6B | -$524M | -$1.2B | |
| Free Cash Flow | $7.5B | $5.5B | $245M | $885M | -$1.1B | |
CNC
Sector
Market Cap
$31.6B
$49.2M
Price % of 52-Week High
76.9%
48.64%
Dividend Yield
0%
0%
Shareholder Yield
5.84%
-0.74%
1-Year Price Total Return
-19.09%
-30.44%
Beta (5-Year)
0.448
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$61.22
200-day SMA
Sell
Level
$69.57
Bollinger Bands (100)
Sell
Level
59.19 - 74.43
Chaikin Money Flow
Buy
Level
209M
20-day SMA
Buy
Level
$59.81
Relative Strength Index (RSI14)
Buy
Level
62.01
ADX Line
Buy
Level
38.25
Williams %R
Sell
Level
-17.9267
50-day SMA
Buy
Level
$60.19
MACD (12, 26)
Buy
Level
0.48
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
158M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.65)
Sell
CA Score
(Annual)
Level (-0.3513)
Buy
Beneish M-Score
(Annual)
Level (-2.7425)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.4886)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract.
Stock Forecast FAQ
In the current month, CNC has received 8 Buy ratings 6 Hold ratings, and 1 Sell ratings. The CNC average analyst price target in the past 3 months is $78.92.
-
Where Will Centene Stock Be In 1 Year?
According to analysts, the consensus estimate is that Centene share price will rise to $78.92 per share over the next 12 months.
-
What Do Analysts Say About Centene?
Analysts are divided on their view about Centene share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Centene is a Sell and believe this share price will drop from its current level to $52.00.
-
What Is Centene's Price Target?
The price target for Centene over the next 1-year time period is forecast to be $78.92 according to 15 Wall Street analysts, 8 of them rate the stock a Buy, 1 rates the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is CNC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Centene is a Buy. 8 of 15 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CNC?
You can purchase shares of Centene via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Centene shares.
-
What Is The Centene Share Price Today?
Centene was last trading at $62.90 per share. This represents the most recent stock quote for Centene. Yesterday, Centene closed at $62.61 per share.
-
How To Buy Centene Stock Online?
In order to purchase Centene stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is up 0.15% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is up 4.07% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 8.59% over the past day.
